Cytochrome P450 inhibitor, TOK-001, Purity ≥98%

Cat. No.: X24-08-YM385

Cytochrome P450 inhibitor, TOK-001, Purity ≥98%

Synonym: 851983-85-2; VN/124-1; Galeterone; (3S,8R,9S,10R,13S,14S)-17-(Benzimidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-ol

  • MDL: MFCD16660907
  • CAS Number: 851983-85-2
  • Compound CID: 11188409
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
TOK-001, soluble in DMSO and warmed ethanol and insoluble in water, is an effective cell metabolism inhibitor, that has the ability to prevent the pathway of metabolism by inhibiting cytochrome P450. It targets the androgen receptor and CYP17.
Molecular Weight
388.3
Molecular Formula
C26H32N2O
Targets
Androgen Receptor: 384 nM; CYP17: 300 nM
Form
Lyophilized powder
Purity
≥98%
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Solubility
In vitro: DMSO: 21 mg/mL (54.04 mM); Water: insoluble; Ethanol (warmed): 36 mg/mL (92.65 mM); In vivo: 0.5% hydroxyethyl cellulose, 28 mg/mL
Stability
In its lyophilized form, the chemical remains stable for 36 months.
Quality Level
Research grade
Applications
TOK-001 is a metabolism inhibitor that plays a key role in blocking the effects of androgens, which are hormones that drive prostate cancer cell growth.
Storage
Store at -20ºC, and keep desiccated.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.